Young-Min Lee

Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy

It is proposed that the future maturation of PCVs will require a coordinated process across five interconnected dimensions: advances in neoantigen prediction technologies, rapid delivery of PCVs to patients, an increase in anticancer efficacy through combination therapy strategies, establishment of cost-effective manufacturing processes, and regulatory innovation.